| Ytd | -91.42% | |
| 1y | -98.40% |
| Open | 1.25 | Prev Close | 1.22 | Low | 1.15 | High | 1.25 | Mkt Cap | 2.62M |
| Vol | 43.70K | Avg Vol | 3.94M | EPS | -8.04 | P/E | -0.14 | Forward P/E | N/A |
| Beta | 3.52 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.48 | 200-d Avg | 7.51 | 1yr Est | 0.00 |
Further improvements can be made with complementary treatment modalities such as PRP that target the
Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday'
Propanc Biopharma, Inc. (NASDAQ:PPCB) ("Propanc" or the "Company"), a biopharmaceuti
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's
Friedman Industries Inc (NASDAQ: FRD) rose in pre-market trading after posting strong Q4 earnings. O